Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Bausch + Lomb Corporation has recently launched the StableVisc™ cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc™ Viscoelastic System in the United States. These new products offer eye surgeons dual-action protection during cataract surgery, expanding the range of options available.…

Haag-Streit has recently launched EyeSuite software version i9.13, which comes with new features for the Anterior Chamber Suite of the Eyestar 900, as well as market-first functionality for the Lenstar Myopia. Furthermore, Haag-Streit has made additional improvements to its existing…

Nicox SA announced that its exclusive Chinese partner, Ocumension Therapeutics, has submitted a new drug application (NDA) seeking approval for commercialization of Zerviate (cetirizine ophthalmic solution), 0.24%, in China. The intended use of Zerviate is for the treatment of ocular…

Peeq Pro has introduced the Peeq Waiva, an innovative at-home cleansing device specifically designed for daily use in cleaning eyelids and the surrounding skin. This device is intended to be used consistently as part of a patient’s eye cleansing routine,…

Horizon Therapeutics has announced positive and statistically significant topline results from its randomized, double-masked, placebo-controlled Phase 4 clinical trial evaluating TEPEZZA for the treatment of adults with chronic thyroid eye disease (TED) and low CAS, a measure of disease activity.…
Targeting angiogenesis in oncology, ophthalmology and beyond Nature Source: Author: | Date: 2023-04-11 07:00:00 Source: Author: | Date: 2023-04-11 07:00:00

Johnson & Johnson Vision has announced the appointment of Lori Tierney as President, Americas; Jacqueline Henderson as President, EMEA; and Christoph Vonwiller as President, Asia Pacific. Ms. Tierney brings her experience as the former President of Americas for the Vision…

Eversight, a nonprofit eye bank, announced the availability of Descemet’s membrane endothelial keratoplasty (DMEK) tissue preloaded in EndoGlide, which offers corneal surgeons an additional preloaded DMEK option, making it the fourth one, that helps in making the surgery more efficient…

AstraZeneca’s Ultomiris (ravulizumab) has received a recommendation for marketing authorization in the European Union (EU) for the treatment of adult patients who are anti-aquaporin-4 (AQP4) antibody positive (Ab+) and have neuromyelitis optica spectrum disorder (NMOSD). If authorized, Ultomiris would become…

The World Council of Optometry (WCO) and Alcon are extending an invitation to eye care professionals worldwide to join them at the launch of a new tool that aids in the diagnosis and treatment of dry eye disease. Interested parties…